Clinical trial
A Phase 1 Study of LY3200882 in Patients With Solid Tumors
NCT02937272 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of LY3200882 in Patients With Solid Tumors
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- November 21, 2016
- Completion date
- August 31, 2027
- Enrollment
- 223 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor